Table of Contents

Global Renal Denervation Treatment Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Renal Denervation Treatment Market Size 2014-2024
  • 2.1.2 Renal Denervation Treatment Market Size CAGR by Region
• 2.2 Renal Denervation Treatment Segment by Type
  • 2.2.1 Radiofrequency
  • 2.2.2 Radiofrequency
• 2.3 Renal Denervation Treatment Market Size by Type
  • 2.3.1 Global Renal Denervation Treatment Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Renal Denervation Treatment Market Size Growth Rate by Type (2014-2019)
• 2.4 Renal Denervation Treatment Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Ambulatory Surgical Centers
  • 2.4.3 Others
• 2.5 Renal Denervation Treatment Market Size by Application
  • 2.5.1 Global Renal Denervation Treatment Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Renal Denervation Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Renal Denervation Treatment by Players

• 3.1 Global Renal Denervation Treatment Market Size Market Share by Players
  • 3.1.1 Global Renal Denervation Treatment Market Size by Players (2017-2019)
  • 3.1.2 Global Renal Denervation Treatment Market Size Market Share by Players (2017-2019)
• 3.2 Global Renal Denervation Treatment Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Renal Denervation Treatment by Regions

• 4.1 Renal Denervation Treatment Market Size by Regions
• 4.2 Americas Renal Denervation Treatment Market Size Growth
• 4.3 APAC Renal Denervation Treatment Market Size Growth
• 4.4 Europe Renal Denervation Treatment Market Size Growth
• 4.5 Middle East & Africa Renal Denervation Treatment Market Size Growth

5 Americas

• 5.1 Americas Renal Denervation Treatment Market Size by Countries
• 5.2 Americas Renal Denervation Treatment Market Size by Type
• 5.3 Americas Renal Denervation Treatment Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Renal Denervation Treatment Market Size by Countries
• 6.2 APAC Renal Denervation Treatment Market Size by Type
• 6.3 APAC Renal Denervation Treatment Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Renal Denervation Treatment by Countries
• 7.2 Europe Renal Denervation Treatment Market Size by Type
• 7.3 Europe Renal Denervation Treatment Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Renal Denervation Treatment by Countries
• 8.2 Middle East & Africa Renal Denervation Treatment Market Size by Type
• 8.3 Middle East & Africa Renal Denervation Treatment Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Renal Denervation Treatment Market Forecast

• 10.1 Global Renal Denervation Treatment Market Size Forecast (2019-2024)
• 10.2 Global Renal Denervation Treatment Forecast by Regions
  • 10.2.1 Global Renal Denervation Treatment Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Renal Denervation Treatment Forecast by Type
• 10.8 Global Renal Denervation Treatment Forecast by Application

11 Key Players Analysis

• 11.1 Cardiosonic
  • 11.1.1 Company Details
  • 11.1.2 Renal Denervation Treatment Product Offered
  • 11.1.3 Cardiosonic Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Cardiosonic News
• 11.2 Theragenics Corporation
  • 11.2.1 Company Details
  • 11.2.2 Renal Denervation Treatment Product Offered
  • 11.2.3 Theragenics Corporation Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Theragenics Corporation News
• 11.3 ReCor Medical
  • 11.3.1 Company Details
  • 11.3.2 Renal Denervation Treatment Product Offered
  • 11.3.3 ReCor Medical Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 ReCor Medical News
• 11.4 St. Jude Medical
  • 11.4.1 Company Details
  • 11.4.2 Renal Denervation Treatment Product Offered
  • 11.4.3 St. Jude Medical Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 St. Jude Medical News
• 11.5 Medtronic
  • 11.5.1 Company Details
  • 11.5.2 Renal Denervation Treatment Product Offered
  • 11.5.3 Medtronic Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Medtronic News
• 11.6 Boston Scientific
  • 11.6.1 Company Details
  • 11.6.2 Renal Denervation Treatment Product Offered
  • 11.6.3 Boston Scientific Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Boston Scientific News
• 11.7 Terumo Corporation
  • 11.7.1 Company Details
  • 11.7.2 Renal Denervation Treatment Product Offered
  • 11.7.3 Terumo Corporation Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Terumo Corporation News
• 11.8 Kona medical
  • 11.8.1 Company Details
  • 11.8.2 Renal Denervation Treatment Product Offered
  • 11.8.3 Kona medical Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.8.4 Main Business Overview
  • 11.8.5 Kona medical News
• 11.9 Abbott Laboratories
  • 11.9.1 Company Details
  • 11.9.2 Renal Denervation Treatment Product Offered
  • 11.9.3 Abbott Laboratories Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.9.4 Main Business Overview
  • 11.9.5 Abbott Laboratories News
• 11.10 Mercator Medsystems
  • 11.10.1 Company Details
  • 11.10.2 Renal Denervation Treatment Product Offered
  • 11.10.3 Mercator Medsystems Renal Denervation Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.10.4 Main Business Overview
  • 11.10.5 Mercator Medsystems News

12 Research Findings and Conclusion

According to this study, over the next five years the Renal Denervation Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Renal Denervation Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Renal Denervation Treatment market by product type, application, key companies and key regions.

This study considers the Renal Denervation Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Radiofrequency
Ultrasound

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Ambulatory Surgical Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Cardiosonic
Theragenics Corporation
ReCor Medical
St. Jude Medical
Medtronic
Boston Scientific
Terumo Corporation
Kona medical
Abbott Laboratories
Mercator Medsystems

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Renal Denervation Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Renal Denervation Treatment market by identifying its various subsegments.
Focuses on the key global Renal Denervation Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Renal Denervation Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Renal Denervation Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.